AsymBio
One-stop CDMO for conjugated drugs, antibodies, and recombinant proteins
AsymBio is a CDMO providing one-stop biopharmaceutical manufacturing solutions for conjugated drugs, antibodies, and recombinant proteins, with capabilities spanning early-stage research through commercial-scale production.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Manufacturing (M)
Services
About this organization
AsymBio, a strategic business of Asymchem Group, focuses exclusively on biopharmaceutical CDMO services. The company leverages advanced technology platforms and extensive project experience to deliver one-stop CDMO solutions for novel conjugated drugs, antibodies, and recombinant protein drugs. Capabilities span early-stage research, process development, toxicology batches, clinical batches, and commercial-scale manufacturing. AsymBio is committed to becoming a trustworthy partner for global biopharmaceutical clients, empowering biopharmaceutical innovation and accelerating drug commercialization.
Recent news about AsymBio
Related companies
Similar profiles by shared services, modalities, and capabilities.
Celonic- Process Development
- Recombinant Protein Manufacturing
JSR Life Sciences- Recombinant Protein Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
Abzena- Process Development
- Recombinant Protein Manufacturing
Creative Biolabs- Process Development
- Recombinant Protein Manufacturing
WuXi Biologics- Process Development
- Recombinant Protein Manufacturing
Piramal Pharma Solutions- Process Development
- Recombinant Protein Manufacturing
KBI Biopharma, Inc.- Process Development
- Recombinant Protein Manufacturing
Cytovance Biologics- Process Development
- Recombinant Protein Manufacturing
Submit a verified review for this organization.
Markdown mirror: /companies/asymbio.md